VoC videos serve a dual purpose. On one hand, they are a comprehensive educational instrument designed to immerse medical device engineers and developers into the lived experiences of their users. On the other hand, they act as an invaluable resource for educating students in biomedical engineering about the real-world applications and implications of their work. By incorporating direct feedback and narratives from actual users, these videos emphasize the necessity of empathy in design processes, thereby enhancing the overall quality and effectiveness of medical devices.

The primary driver behind the creation of VoC videos is the recognition that technical specifications alone do not capture the full scope of user experiences. Patients often face numerous challenges when interacting with medical devices, which can lead to poor adherence, compromised health outcomes, and increased frustration. While engineers can design devices to meet regulatory standards, they may overlook the emotional and psychological dimensions of device usage. VoC videos fill this critical void by putting a human face to the clinical needs, targeting emotional resonance while also informing technical developments.

A variety of patient experiences were documented in these videos, ranging from chronic condition management to acute care scenarios. Through firsthand narratives, users describe the impacts of device interfaces on their daily lives, showcasing both their struggles and triumphs. For example, patients with diabetes share their experiences with glucose monitors, emphasizing the importance of intuitive design and ease of use, while healthcare professionals highlight the need for devices that integrate seamlessly into existing workflows. Capturing these diverse perspectives not only informs product design but also encourages an ongoing dialogue between users and designers throughout the development cycle.

The method by which these videos were created combines qualitative research techniques with audio-visual storytelling. Researchers conducted interviews with patients, caregivers, and healthcare workers, utilizing a narrative structure to present their stories compellingly. This approach ensures that the emotional weight of their experiences is conveyed alongside factual information. The resulting videos do not simply educate developers but provoke empathy, fostering a deeper connection that is often missing in traditional educational settings.

Incorporating VoC videos into biomedical engineering curricula presents a significant opportunity for transformation in medical device education. The traditional paradigm has emphasized technical capabilities, often at the expense of understanding user needs. By challenging this perspective, educators can cultivate a generation of engineers who not only excel in designing innovative technology but also prioritize user-centric solutions. The addition of these videos into coursework encourages students to think critically about the implications of their designs, motivating them to consider the broader impact on patient lives.

The implementation of VoC videos has also been linked to improved project outcomes. Engineering teams that have engaged with these narratives often demonstrate increased levels of creativity and problem-solving capabilities. This is likely due to the newfound empathy, which drives teams to brainstorm innovative designs that could better accommodate user needs. Case studies illustrate that teams employing a VoC approach achieve higher satisfaction among users, leading to more successful product launches and higher market acceptance.

In a broader sense, the growth of empathy-driven design practices within the medical device industry reflects shifting trends in healthcare. As patients become increasingly involved in their care and decision-making processes, their voices are crucial. VoC videos align with the principles of patient-centered care, promoting an ethos where the patient’s perspective informs every aspect of medical technology. This trend also intersects with advancements in telemedicine and remote monitoring, where understanding user experience is paramount to ensuring widespread adoption and effective usage.

Moreover, as the landscape of healthcare becomes more digital and interconnected, the role of education must also evolve. Medical professionals now require training that extends beyond clinical knowledge to encompass skills in digital literacy, user experience, and design thinking. VoC videos present a compelling solution, offering an accessible yet impactful means of imparting these lessons. The visual medium is particularly effective in conveying messages that could be lost in traditional, text-based educational formats.

Within the academic community, early adopters of this educational strategy report positive feedback from both students and faculty. Students often express a sense of empowerment after engaging with VoC materials, feeling more equipped to contribute to meaningful design innovations. Instructors note a profound shift in student engagement levels, as the videos spark discussions, inspire creative thinking, and deepen understanding of complex issues surrounding medical devices.

In conclusion, the introduction of Voice of the Customer videos stands as a promising development within the education of biomedical engineers and the broader medical device industry. By placing user experiences at the forefront, these videos challenge traditional paradigms, fostering empathy that could lead to innovations that are not only technologically advanced but also genuinely beneficial to patients. As this educational tool continues to evolve, it may well become a cornerstone of future medical device design, shaping a future where technology and human experience work hand in hand.

The commitment to integrating patient narratives into the fabric of medical device development echoes a larger movement towards a more humane healthcare system, where understanding the patient experience is not merely an afterthought but a guiding principle. Emphasizing the importance of this empathetic approach can only serve to enhance the quality of healthcare technologies and improve outcomes for patients worldwide.

If the medical community can continue to harness the power of stories and perspectives captured within VoC videos, the possibilities for innovation in medical devices will truly be boundless. It is through these interactions that engineers and developers will achieve not just functionality but also compassion, ensuring that future designs resonate with users’ needs and values.

Subject of Research: Voice of the Customer in medical device design and education.

Article Title: Voice of the Customer Videos: An Educational Tool to Identify Unmet Clinical Needs and Develop Empathy for Medical Device Users.

Article References:
Rooney, S.I., Jelenewicz, S.M. Voice of the Customer Videos: An Educational Tool to Identify Unmet Clinical Needs and Develop Empathy for Medical Device Users.
Biomed Eng Education (2025). https://doi.org/10.1007/s43683-025-00206-5

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s43683-025-00206-5

Keywords: Voice of the Customer, medical device design, empathy in engineering, patient-centered care, biomedical education.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant attention for its capacity to support weight loss while regulating glycemic control. Originally developed for individuals with type 2 diabetes, clinical evidence has shown its efficacy in promoting substantial weight reductions among non-diabetic populations. However, the transition from controlled clinical trials to practical, everyday settings reveals a different landscape—one that this study seeks to navigate by incorporating the WeGoTogether digital platform.

The WeGoTogether application represents a modern approach to patient engagement, marrying pharmacological interventions with behavioral support through technology. It offers users access to community support, educational resources, tracking tools, and other functionalities aimed at fostering adherence to weight loss regimens. This dual approach—medication coupled with digital support—aims to empower patients, making them active participants in their health journey. Understanding how these two elements interact can provide invaluable data on how to optimize treatment outcomes.

Participants in the study were observed to initiate treatment with Semaglutide 2.4 mg, reporting their experiences through the WeGoTogether platform over a specified period. The results yielded remarkable insights into both behavioral modifications and actual weight loss numbers, illuminating pathways for successful weight management strategies among various patient demographics. Even though Semaglutide has proven effective in clinical settings, translating those results to a real-world context illuminates the significance of ongoing support and encouragement.

Weight loss is often perceived as an uphill battle, deeply intertwined with individual psychology, environment, and access to resources. As such, the intervention of a digital application designed specifically for self-support stands out as an innovative solution. By enabling users to share their personal goals, challenges, and triumphs, WeGoTogether fosters a sense of community among participants. This study highlights how environmental factors combined with a robust medication like Semaglutide can create an ecosystem conducive to sustainable lifestyle changes.

An intriguing aspect of the research is the examination of adherence to both the medication and the WeGoTogether platform itself. Maintaining consistent use of Semaglutide is essential for the drug to manifest its weight-loss effects, while the continuous engagement with the application plays a vital role in motivating participants. Insights from the study suggest that users who remained active on the platform demonstrated greater weight loss and more significant behavioral changes compared to those who did not extensively utilize the application.

This suggests a symbiotic relationship between pharmacological treatment and digital health solutions, which could reshape how obesity is managed on a broader scale. Not merely dependent on the medication’s effectiveness, weight loss can significantly improve when supported by peer interactions and motivation. The implications of this are profound; it opens avenues for future research to explore the development and integration of similar platforms within traditional treatment frameworks.

Particularly noteworthy is the demographic diversity observed in the participants, consisting of various age groups, ethnic backgrounds, and pre-existing health conditions. Such a broad spectrum enhances the study’s validity, connecting findings to the larger population facing obesity—an issue that does not discriminate by age or ethnicity. By analyzing weight loss outcomes across these diverse backgrounds, the researchers are able to provide tailored recommendations that can be adapted to different patient profiles.

Another significant point addressed in the research is the psychological aspect of weight loss. The interaction between using the WeGoTogether app and the transformative journey of adopting Semaglutide invites exploration into self-efficacy and motivation. A key finding illustrates how users who are part of an encouraging community tend to have higher rates of self-motivation and are more likely to overcome barriers that typically discourage weight loss efforts.

Additionally, the longitudinal nature of the study offers compelling insights into how sustained use of both medication and digital support can lead to long-term weight management success. Traditional methods often emphasize initial weight loss, but this research indicates the vital importance of ongoing support and flexibility in treatment to foster lasting change.

The potential to expand the application of Semaglutide, in tandem with digital solutions like WeGoTogether, poses a fantastic opportunity for healthcare providers. Considering the increasing prevalence of obesity-related health issues, integrating innovative approaches into standard care protocols could result in significant improvements in patient health outcomes and quality of life.

In conclusion, the Toliver et al. study shines a light on a promising model combining modern pharmacotherapy with digital behavioral support in treating obesity. As more people turn to technology for assistance in managing their health, the insights from this research could spur a new wave of obesity treatment strategies that prioritize personalization and community involvement. The holistic approach illustrated in this study heralds a shift towards comprehensive care, where every aspect of a patient’s journey is valued and nurtured.

Continued research in this area is crucial to understanding the full breadth of the interaction between medication efficacy and digital support mechanisms. The results not only hold promise for addressing the growing obesity epidemic but also lay the groundwork for future innovations that could improve treatment paradigms across a range of chronic conditions.

Subject of Research: Real-world weight loss outcomes with Semaglutide 2.4 mg coupled with digital support.

Article Title: Real-World Weight Loss Among Patients Initiating Semaglutide 2.4 mg and Enrolled in WeGoTogether, a Digital Self-Support Application.

Article References:
Toliver, J.C., Divino, V., Ng, C.D. et al. Real-World Weight Loss Among Patients Initiating Semaglutide 2.4 mg and Enrolled in WeGoTogether, a Digital Self-Support Application.
Adv Ther (2025). https://doi.org/10.1007/s12325-025-03325-1

Image Credits: AI Generated

DOI: 10.1007/s12325-025-03325-1

Keywords: Semaglutide, weight loss, digital health, obesity management, real-world evidence.